Table of contents

Original articles

• TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations

  (20 June, 2011) Free

  Young-Ho Kim, Daniela Pierscianek, Michel Mittelbronn, Anne Vital, Luigi Mariani, Martin Hasselblatt, Hiroko Ohgaki
• Claudin and p53 expression in vulvar lichen sclerosus and squamous-cell carcinoma (4 June, 2011)

  José Carlos Sadalla, Sílvia Vanessa Lourenço, Mirian Nacagami Sotto, Edmund Chada Baracat, Jesus Paula Carvalho
• Evaluation of the clinical efficacy of minimally invasive procedures for breast cancer screening at a teaching hospital (10 June, 2011)

  Beatriz Daou Verenhitach, Simone Elias, Ana Claudia Patrocínio, Afonso Celso Pinto Nazário, Angela Waizberg
• Rule-based decision support system in the biopsy diagnosis of glomerular diseases (10 June, 2011)

  Ruchika Gupta, Alok Sharma, Sompal Singh, Amit K Dinda
• BCL-6 expression in mesenchymal tumours: an immunohistochemical and fluorescence in situ hybridisation study (1 July, 2011)

  Matthew P Walters, Ellen D McPhail, Mark E Law, Andrew L Folpe
• A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma (22 September, 2011)

  Tinte Itinteang, Swee T Tan, Siobhan Guthrie, Cherise E S Tan, Ben C McIntyre, Helen D Brasch, Darren J Day
• Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification (24 June, 2011)

  Kohichi Yamauchi, Yasunori Fujioka, Yasunao Kogashiwa, Naoyuki Kohno
• Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples (14 July, 2011)

  Benedict Yan, Ee Xuan Yau, Shoa Nian Choo, Chee Wee Ong, Kol Jia Yong, Brendan Pang, Manuel Salto-Tellez
• EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy (22 September, 2011)

  Erik Thunnissen, Judith V M G Bovée, Hans Bruinsma, Adriaan J C van den Brule, Winand Dinjens, Daniëlle A M Heideman, Els Meulemans, Petra Nederlof, Carel van Noesel, Clemens F M Prinsen, Karen Scheidel, Peter M van de Ven, Roel de Weger, Ed Schuuring, Marjolijn Ligtenberg
• PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma (1 July, 2011)

  Jung-Woo Choi, Ju-Han Lee, Hong Seok Park, Young-Sik Kim
• The frequency of detection of unexpected diabetes mellitus during haemoglobinopathy investigations (5 July, 2011)

  Mary Conroy, Philip Beer, Carol Hughes, Lorraine Phelan, Barbara J Bain
• Comparison between the Midi Parasep and Midi Parasep Solvent Free (SF) faecal parasite concentrators (16 June, 2011)

  Agatha C Saez, Monika M Manser, Nick Andrews, Peter L Chiodini
• Locked nucleic acid probes for enhanced detection of FLT3 D835/I836, JAK2 V617F and NPM1 mutations (10 June, 2011) Free

  Ilka Warshawsky, Frank Mularo
• Expression of phosphoinositide-specific phospholipase C isoforms in human umbilical vein endothelial cells (8 July, 2011)

  V R Lo Vasco, L Pacini, T Di Raimo, D D'arcangelo, R Businaro
• Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: The role in primary care setting (13 June, 2011)

  C Rinaldi A Lesmana, Simon Salim, Irsan Hasan, Andri S Sulaiman, Rino A Gani, Levina S Pakasi, Laurentius A Lesmana, Ening Krisnuhoni, Unggul Budihusodo